Prediction Case File
YouTubeTracking Live

Friends! In this video, I'm going to analyze Mercado Libre Stock and Amazon stock

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
20 Oct 2025, 22:27 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to analyze Mercado Libre Stock and Amazon stock
Source overview

AI-generated source summary

The video discusses MercadoLibre (MELI) and Amazon (AMZN) as stocks that could double in four years. MELI is analyzed with a current price of $2024.98, down 18% on the month, a target price of $5003.83 with 19.6% annyal return and an implied failure price of $2502. The presenter uses different charts to analyze MELI, focusing on unique active buyers, 1.8 Billion Items Sold in 2024 over 50% FBM penetration, network, and sustanaibility; emphasizing a leadership in e-commerce and financial services in Latin America. On the other hand, it is mentioned that revenues increased 617% and earning per share increased 2532% since 2021, going from 743x PE to 40x but the stock price is up only 4%. It is stated that MELI has 100 million unique active buyers and the delivery is in less than 48 hours. The price to operating cash flow for Amazon is at 14x, it trades under $30B. AMZN is expected to return more than 20% annually.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.6
Tracked signals
324
Historical success
34.4%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail